STOCK TITAN

[SCHEDULE 13G/A] Neuronetics, Inc. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Neuronetics, Inc. filing amends beneficial ownership disclosure for Jorey Chernett. As of the close of business on March 17, 2026, the Reporting Person beneficially owned 7,516,404 shares of Common Stock, representing 10.85% of the class based on 69,276,593 Shares outstanding as of March 10, 2026.

The amendment updates the Schedule 13G/A ownership figures and reports sole voting and dispositive power over the disclosed shares. The statement is signed and dated 03/18/2026.

Positive

  • None.

Negative

  • None.

Insights

Disclosure clarifies a >10% stake by an individual investor.

The filing documents that Jorey Chernett beneficially owns 7,516,404 shares, equal to 10.85% of outstanding common stock using the issuer's stated outstanding share count of 69,276,593 as of March 10, 2026. This meets the Schedule 13G/A threshold for beneficial owner reporting.

The primary dependency is the issuer's outstanding share count cited from the Form S-3; any future updates to outstanding shares would change the percent calculation. Subsequent filings could adjust ownership percentages if shares are acquired or disposed.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Chernett Jorey
Signature:/s/ Jorey Chernett
Name/Title:Jorey Chernett
Date:03/18/2026
Neuronetics

NASDAQ:STIM

View STIM Stock Overview

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

93.14M
33.96M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN